Important regulatory notice. Retatrutide is investigational and not licensed in the United Kingdom for human or veterinary use. Tirzepatide (Mounjaro) is licensed in the United Kingdom for type 2 diabetes and weight management on the prescription of a registered prescriber. This page is a research-context comparison of receptor pharmacology, trial design and UK regulatory status.…
